Response and Disease Dynamics in Untreated Metastatic Colorectal Cancer With Bevacizumab-Based Sequential vs. Combination Chemotherapy—Analysis of the Phase 3 XELAVIRI Trial

Overview of attention for article published in Frontiers in oncology, February 2022

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 1 Dimensions

Readers on

mendeley: 4 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 1 X users, with an upper bound of 6,540 followers.

📣 Original article: Response and Disease Dynamics in Untreated Metastatic #ColorectalCancer With Bevacizumab-Based Sequential vs. Combination Chemotherapy—Analysis of the Phase 3 XELAVIRI Trial 👨‍⚕️👩‍⚕️ Kurreck A 👉 https://t.co/6DCH3baCEe @ArndtStahler

28 Feb 2022

Reply Repost Favourite

New research: Response and Disease Dynamics in Untreated Metastatic Colorectal Cancer With Bevacizumab-Based Sequential vs. Combination Chemotherapy—Analysis of the Phase 3 XELAVIRI Trial: Introduction Early tumor shrinkage (ETS), depth of… https://t.co/3

18 Feb 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.